Blog

The Max Foundation Celebrates Partnership with Yeolyan Center in Armenia

The Max Foundation/LinkedIn

May 25, 2025, 13:47

The Max Foundation Celebrates Partnership with Yeolyan Center in Armenia

The Max Foundation shared a post on LinkedIn:

“This month we had the honor of visiting our long-standing partner, the Yeolyan Hematology and Oncology Center in Yerevan. Since 2003, our collaboration has helped bring hope and healing to over 900 patients facing cancer and blood diseases.

Dr. Hayk Grigoryan and his dedicated team warmly welcomed our CEO Pat-Garcia-Gonzalez and accompanying team members. Together, we’ve worked to ensure access to life-extending treatments—including medications for chronic myeloid leukemia, acute lymphoblastic leukemia, gastrointestinal stromal tumor, and lung cancer—as well as essential diagnostic tools like PCR testing.

During our visit, we toured the center’s new facilities, including the Aryan Bank building and the bone marrow transplant department. We were deeply moved to receive a letter of gratitude and the Professor R. Yeolyan Memorial Medal, a symbol of our shared commitment to saving lives.

This partnership is built on a simple but powerful belief: no one should be left behind because they can’t afford treatment. We are proud to stand with Yeolyan Center in this mission—and excited for the future we will build together.”

The Max Foundation marked its ongoing collaboration with the Yeolyan Hematology and Oncology Center in Armenia, celebrating two decades of work that has provided critical cancer treatments and diagnostics to hundreds of patients.

More posts featuring The Max Foundation.

Acute Lymphoblastic Leukemia Armenia Aryan Bank Bone Marrow Transplant cancer chronic myeloid leukemia fight against cancer gastrointestinal stromal tumor Global fight against cancer Hayk Grigoryan Lung cancer OncoDaily Oncology Pat Garcia-Gonzalez PCR testing R. Yeolyan Memorial Medal The Max Foundation Yeolyan Center Yeolyan Hematology and Oncology Center Yerevan

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Penn Medicine: Cancer Center Near Me

Elevating Childhood Cancer and Catastrophic Diseases in the Global NCD Agenda: Joint Call to Action

King Hussein Cancer Research Award: Don’t Miss Your Chance to Apply